Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease
- 22 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 23 (4), 698-707
- https://doi.org/10.1038/leu.2008.359
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24Molecular Cancer Research, 2008
- CD4+/CD56+ Hematodermic Neoplasm (“Blastic Natural Killer Cell Lymphoma”)American Journal of Clinical Pathology, 2007
- Comparison of a quantitative PCR method with FISH for the assessment of the four aneuploidies commonly evaluated in CLL patientsLeukemia, 2007
- CD4+/CD56+ Hematodermic TumorAmerican Journal of Clinical Pathology, 2007
- Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?British Journal of Haematology, 2007
- Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entitiesBlood, 2006
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique HematologiqueBlood, 2002
- p53 Mutations in Nasal Natural Killer/T-Cell Lymphoma from Mexico: Association with Large Cell Morphology and Advanced DiseaseThe American Journal of Pathology, 2001
- Identification of a leukemic counterpart of the plasmacytoid dendritic cellsBlood, 2001